Hansa Biopharma AB (LTS:0RC7)
kr 34.48 -0.57 (-1.63%) Market Cap: 3.42 Bil Enterprise Value: 3.89 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 63/100

Hansa Biopharma AB at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 06:30 PM GMT
Release Date Price: kr32.8


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HNSA.ST - Hansa Biopharma AB
Hansa Biopharma AB at JPMorgan Healthcare Conference
Jan 14, 2026 / 06:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone. Welcome to the 2026 JPMorgan Healthcare Conference. My name is Varun, and it is my absolute pleasure to invite on stage Hansa BioPharma, represented by the CEO Rene Aguele Lukander, and to talk about the company and their vision moving forward. Please put your hands together for Rene.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Welcome everybody. We're going to walk through a presentation that has some forward-looking statements, so I refer you to our filings, including those including the related to risk factors.

So in terms of Hansa
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot